Literature DB >> 15221309

Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema.

Remzi Avci1, Berkant Kaderli, Berrin Avci, Saban Simsek, Mehmet Baykara, Zeynep Kahveci, Oner Gelisken, Ahmet Ali Yucel.   

Abstract

BACKGROUND: To evaluate the results of pars plana vitrectomy with peeling of the internal limiting membrane (ILM) in eyes with chronic macular oedema.
METHODS: PPV with indocyanine green (ICG) assisted peeling of the ILM was performed in 33 eyes with diabetic (21 eyes) or non-diabetic (12 eyes) macular oedema. Postoperatively, resolution of macular oedema, improvement of visual acuity (VA) and complications were documented. The peeled membranes were submitted for light and transmission electron microscopic evaluation.
RESULTS: The mean follow-up time was 12.2 months. The macular oedema decreased or was resolved in 17 (81%) eyes in the diabetic group and in 11 (92%) eyes in the non-diabetic group. VA improved by at least 2 lines in 11 (52%) eyes in the diabetic group and in 7 (58%) eyes in the non-diabetic group. The difference between visual acuity improvements of the two groups was not statistically significant (P>0.05). However, in the diabetic group the difference of visual improvement between cystoid and diffuse type of macular oedema eyes was statistically significant (14% versus 71%, P=0.02). Light and transmission electron microscopy showed the presence of ILM in all specimens. During the follow-up period no recurrence of macular oedema or epiretinal membrane formation was observed.
CONCLUSION: Pars plana vitrectomy with peeling of the ILM and epiretinal membrane leads to the resolution of macular oedema in the majority of eyes. This however, is not always associated with VA improvement. In diabetic eyes, cystoid type of macular oedema appears to be a poor prognostic factor for improved VA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221309     DOI: 10.1007/s00417-004-0939-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  34 in total

1.  Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.

Authors:  S D Pendergast; T S Hassan; G A Williams; M S Cox; R R Margherio; P J Ferrone; B R Garretson; M T Trese
Journal:  Am J Ophthalmol       Date:  2000-08       Impact factor: 5.258

2.  Indocyanine green selectively stains the internal limiting membrane.

Authors:  A Gandorfer; E M Messmer; M W Ulbig; A Kampik
Journal:  Am J Ophthalmol       Date:  2001-03       Impact factor: 5.258

3.  Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion.

Authors:  P Hofman; B C van Blijswijk; P J Gaillard; G F Vrensen; R O Schlingemann
Journal:  Arch Ophthalmol       Date:  2001-06

4.  [Macular edema caused by contraction of the posterior hyaloid in diabetic retinopathy. Surgical treatment of a series of 22 cases].

Authors:  G van Effenterre; C Guyot-Argenton; B Guiberteau; I Hany; J L Lacotte
Journal:  J Fr Ophtalmol       Date:  1993       Impact factor: 0.818

5.  Epiretinal and vitreous membranes. Comparative study of 56 cases.

Authors:  A Kampik; K R Kenyon; R G Michels; W R Green; Z C de la Cruz
Journal:  Arch Ophthalmol       Date:  1981-08

6.  Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.

Authors:  A Gandorfer; E M Messmer; M W Ulbig; A Kampik
Journal:  Retina       Date:  2000       Impact factor: 4.256

7.  Vitrectomy for macular edema combined with retinal vein occlusion.

Authors:  N Tachi; Y Hashimoto; N Ogino
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

8.  Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage.

Authors:  A Gandorfer; C Haritoglou; C A Gass; M W Ulbig; A Kampik
Journal:  Am J Ophthalmol       Date:  2001-09       Impact factor: 5.258

9.  Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane.

Authors:  J W Harbour; W E Smiddy; H W Flynn; P E Rubsamen
Journal:  Am J Ophthalmol       Date:  1996-04       Impact factor: 5.258

10.  Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results.

Authors:  C M Lee; R J Olk
Journal:  Ophthalmology       Date:  1991-10       Impact factor: 12.079

View more
  9 in total

1.  Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema.

Authors:  Atul Kumar; Subijay Sinha; Rajvardhan Azad; Yog Raj Sharma; Rajpal Vohra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-09       Impact factor: 3.117

2.  Cystoid puncture for chronic cystoid macular oedema.

Authors:  Rishi P Singh; Ronald Margolis; Peter K Kaiser
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

3.  Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study.

Authors:  S P Shah; M Patel; D Thomas; S Aldington; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

4.  Dilute triamcinolone-assisted peeling of the internal limiting membrane in cases of diffuse diabetic macular oedema.

Authors:  Remzi Avci; Berrin Avci; Berkant Kaderli
Journal:  Int Ophthalmol       Date:  2006-12-01       Impact factor: 2.031

5.  Mid-term safety and effectiveness of intravitreal dexamethasone implant to treat persistent cystoid macular edema in vitrectomized eyes for bacterial endophthalmitis.

Authors:  Giancarlo Sborgia; Alfredo Niro; Valentina Pastore; Rosa Anna Favale; Alessandra Sborgia; Samuele Gigliola; Gianluigi Giuliani; Maria Oliva Grassi; Marco Coassin; Francesco Aiello; Cristiana Iaculli; Michele Reibaldi; Francesco Boscia; Giovanni Alessio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-07       Impact factor: 3.535

6.  Morphometry of surgically removed internal limiting membrane during vitrectomy in diabetic macular edema.

Authors:  Jan Kalvoda; Jaroslava Dusková; Ales Kubena; Ctibor Povýsil; Bohdana Kalvodová
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-09       Impact factor: 3.117

7.  Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema.

Authors:  Minhee Cho; Donald J D'Amico
Journal:  Clin Ophthalmol       Date:  2012-07-06

8.  Three-Dimensional Analysis of Peeled Internal Limiting Membrane Using Focused Ion Beam/Scanning Electron Microscopy.

Authors:  Akira Hirata; Kazuhisa Murata; Ken Hayashi; Kei-Ichiro Nakamura
Journal:  Transl Vis Sci Technol       Date:  2018-02-02       Impact factor: 3.283

9.  Evaluation of the efficacy of vitrectomy for persistent diabetic macular edema and associated factors predicting outcome.

Authors:  Su Jeong Song; Joon Hong Sohn; Kyu Hyung Park
Journal:  Korean J Ophthalmol       Date:  2007-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.